# A Study of AZD0120 in Autoimmune Diseases

> **NCT07295847** · PHASE1 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 27 (estimated)

## Conditions studied

- Systemic Sclerosis
- Idiopathic Inflammatory Myopathies
- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** AZD0120

## Key facts

- **NCT ID:** NCT07295847
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-09
- **Primary completion:** 2028-02-22
- **Final completion:** 2028-02-22
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07295847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07295847, "A Study of AZD0120 in Autoimmune Diseases". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07295847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*